Vanguard Group Inc Vertex Pharmaceuticals Inc Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 23,973,777 shares of VRTX stock, worth $9.3 Billion. This represents 0.18% of its overall portfolio holdings.

Number of Shares
23,973,777
Previous 23,491,161 2.05%
Holding current value
$9.3 Billion
Previous $11.4 Billion 6.29%
% of portfolio
0.18%
Previous 0.21%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$421.16 - $509.5 $203 Million - $246 Million
482,616 Added 2.05%
23,973,777 $10.7 Billion
Q1 2025

May 09, 2025
BUY
$402.49 - $513.76 $93.7 Million - $120 Million
232,873 Added 1.0%
23,491,161 $11.4 Billion
Q4 2024

Feb 11, 2025
BUY
$396.64 - $516.74 $39.1 Million - $51 Million
98,654 Added 0.43%
23,258,288 $9.37 Billion
Q3 2024

Nov 13, 2024
BUY
$460.0 - $505.78 $84.7 Million - $93.1 Million
184,113 Added 0.8%
23,159,634 $10.8 Billion
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $117 Million - $145 Million
299,003 Added 1.32%
22,975,521 $10.8 Billion
Q1 2024

May 10, 2024
BUY
$407.69 - $446.08 $161 Million - $176 Million
394,338 Added 1.77%
22,676,518 $9.48 Billion
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $102 Million - $123 Million
298,824 Added 1.36%
22,282,180 $9.07 Billion
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $29.6 Million - $31.7 Million
87,397 Added 0.4%
21,983,356 $7.64 Billion
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $15.7 Million - $17.5 Million
49,807 Added 0.23%
21,895,959 $7.71 Billion
Q1 2023

Jul 14, 2023
BUY
$283.23 - $323.1 $73,923 - $84,329
261 Added 0.0%
21,846,152 $6.88 Billion
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $84.7 Million - $96.6 Million
298,988 Added 1.39%
21,845,891 $6.88 Billion
Q4 2022

Feb 10, 2023
BUY
$285.76 - $321.48 $118 Million - $133 Million
414,567 Added 1.96%
21,546,903 $6.22 Billion
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $80.5 Million - $89.8 Million
293,861 Added 1.41%
21,132,336 $6.12 Billion
Q2 2022

Aug 12, 2022
BUY
$234.96 - $292.55 $85.8 Million - $107 Million
365,004 Added 1.78%
20,838,475 $5.87 Billion
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $70.3 Million - $82.9 Million
317,629 Added 1.58%
20,473,471 $5.34 Billion
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $50.8 Million - $64.1 Million
-286,849 Reduced 1.4%
20,155,842 $4.43 Billion
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $35.1 Million - $39.3 Million
193,473 Added 0.96%
20,442,691 $3.71 Billion
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $3.8 Billion - $4.48 Billion
20,249,218 New
20,249,218 $4.08 Billion

Others Institutions Holding VRTX

# of Institutions
1,810
Shares Held
232M
Call Options Held
1.51M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $99.5B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email